ThinkWell is working to build country capacity to generate and use of cost evidence for sustainable and predictable financing for immunization
As more low- and middle-income countries transition to self-financed immunization programs, country governments need to understand what it will cost to deliver vaccines to reach coverage goals, address health equity, manage the introduce of new vaccines, and achieve efficiencies. However, cost data are often of variable quality and are difficult to access and use by policymakers, program planners, and other global and country-level stakeholders.
Our goal is to help decision-makers access, understand, and use evidence on the cost of delivering vaccines.
The Immunization Costing Action Network (ICAN)
ThinkWell and John Snow Inc. (JSI) are supporting the Immunization Costing Action Network (ICAN), a research and learning network working to increase the visibility, availability, understanding, and use of immunization delivery cost* information. The ICAN is building country capacity to generate cost evidence that is policy relevant and a priority for the immunization program. The ICAN is also working with countries to improve interpretation and translation of cost evidence so that it is used in country decision-making processes and informs routine planning and budgeting. The ICAN believes that when equipped with relevant and user-friendly cost evidence, immunization managers, program planners, and policymakers will be empowered in fundraising and advocacy efforts and will make better resource allocation decisions, improving the efficiency and equity of immunization programs.
The ICAN is supported by The Bill & Melinda Gates Foundation.
ThinkWell completed a systematic review on the cost of delivering vaccines across different low- and middle-income countries and through a variety of vaccine delivery strategies. From the compiled evidence, ThinkWell developed the Immunization Delivery Cost Catalogue (IDCC) – the most comprehensive, current, and standardized global evidence – and companion products to help interpret the evidence.
COUNTRY RESEARCH & POLICY
The ICAN is comprised of four-member countries – India, Indonesia, Tanzania, and Vietnam – with country teams that include health economist researchers, immunization managers, and planners from Ministries of Health. The country teams are conducting costing studies that explore the cost of delivering vaccines through different delivery strategies to diverse geographies and to distinct target populations. ThinkWell and John Snow, Inc. (JSI) are facilitating the ICAN to encourage cross-country knowledge sharing and co-production of effective strategies for generation and use of cost evidence.
*We define delivery costs as the costs associated with delivering immunizations to target populations, exclusive of vaccine costs. These costs are sometimes referred to as operational costs. Delivery costs may include any or all of the following items: paid and volunteer human resources and associated per diem and travel allowances; cold chain equipment and overheads (e.g. energy, maintenance, repairs); vehicles, transport and fuel; program management; training and capacity building; social mobilization and advocacy; adverse event following immunization (AEFI) and disease surveillance; buildings, utilities, other overheads and shared costs; vaccine supplies (e.g. safety boxes, diluents, reconstitution syringes); waste management; other supplies and recurrent costs; and other non-vaccine costs. For more information, see the definitions list in our Methodology Note.
© 2019, Immunization Costing Action Network (ICAN), ThinkWell, LLC. All rights reserved.